FDA clearance for True Regeneration™ reaches milestone

CERRITOS, Calif., March 15, 2017 /PRNewswire/ — Millennium Dental Technologies, Inc. marks a huge milestone today in the one-year anniversary of the world’s first and only U.S. FDA clearance for full-mouth True Periodontal Regeneration. The LANAP® Protocol with the PerioLase MVP-7 dental laser is the only laser-based gum disease treatment to demonstrate this extraordinary ability to regenerate all three periodontal tissues: alveolar bone, periodontal ligament and cementum lost to disease.

“This unique distinction granted by the FDA a year ago confirmed that the LANAP® Protocol treats periodontal disease in a way that we could previously only dream of,” said Robert H. Gregg II, DDS, co-founder of MDT, inventor of the LANAP® Protocol and co-developer of the PerioLase MVP-7. “Now all patients have a proven no-cut, no-sew science-based treatment to reverse gum disease.”

“With True Regeneration, the LANAP® Protocol has changed the standard of care in periodontal disease treatment,” states Dawn M. Gregg, DDS, CEO & Training Director, the Institute for Advanced Laser Dentistry. “A critical part of informed consent within dentistry is helping patients understand their treatment choices – the choices are do nothing; choose painful and only partially successful repair methods; or choose a highly effective regenerative method. It’s no surprise what patients choose when they want to save their teeth – and their health.”

• 85% of U.S. adults have some level of gum disease; 40% suffer from moderate-to-severe levels.
• Gum disease is linked to systemic diseases including: heart disease, Alzheimer’s, stroke, certain cancers, pre-term birth, diabetes and more.
• LANAP® Protocol is the preferred laser gum disease protocol for over 30% of periodontists and thousands of general dentists
• 90% of patients accept LANAP® treatment
• LANAP® Protocol is now part of legal informed consent

ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Headquartered in Cerritos, Calif.,Millennium Dental Technologies, Inc., is the developer of the LANAP® Protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared LANAP® Protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional surgery. Its PerioLase MVP-7 is a 6-watt free-running variable-pulsed Nd:YAG dental laser featuring 7 pulse durations giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures. The PerioLase MVP-7 is also developed for the LAPIP™ Protocol, for the treatment of ailing dental implants. The company’s founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—and to remain true to the guiding principle—”It’s all about the patient.”